Phase II Anetumab Ravtansine in Pre-treated Mesothelin-expressing Pancreatic Cancer
Clinical trial NCT03023722 · COMPLETED
Trial details
- NCT number
- NCT03023722
- Sponsor
- Yale University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-11
- Primary completion
- 2019-08-06
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.